Report

Safeguarding Against Global Catastrophe

Safeguarding Against Global Catastrophe

Kevin P. O’Prey, PhD

Managing Partner, The Palisades Group LLC

Nikki Teran, PhD

Managing Member, Emerging Technology Solutions LLC

Links & Downloads

Risks, Opportunities, and Governance Options at the Intersection of Artificial Intelligence and Biology

Overview

Imagine this: A global pandemic that results in more than 850 million cases, and 60 million deaths is sparked by a novel enterovirus strain that was intentionally engineered by an extremist group using artificial intelligence–enabled capabilities. This is the fictional scenario that senior leaders grappled with during a tabletop exercise hosted by NTI in partnership with the Munich Security Conference (MSC) in February 2025.

The exercise explored opportunities and risks at the convergence of AI and life sciences (AIxBio), and the resulting report offers practical recommendations to prevent catastrophic misuse.

The key takeaway? The exploitation of AIxBio capabilities for harm is a plausible near-term risk—and the time for action is now.

Exercise Findings

  1. The fictional pandemic facilitated by the exploitation of AIxBio capabilities is a plausible, high-consequence bioterror scenario that technical experts and counter-terrorism professionals find deeply concerning and worthy of near-term action to prevent.
  2. Rapidly advancing AIxBio capabilities are eroding barriers to bioweapons development by malicious actors, while also raising the ceiling of possible harms.
  3. Existing security regimes are not equipped to address AI-enabled biological threats, but multiple intervention opportunities exist to reduce the risk that these capabilities could be exploited for biological weapons development.
  4. AIxBio model developers can lead in developing best practices and technical solutions to reduce risks throughout the AI-model development life cycle.
  5. There is a need for an official forum at the international level for communication and coordination to assess and address AIxBio risks.
  6. Efforts to manage AI risks must take into account the benefits of AIxBio capabilities and avoid placing undue constraints on scientific benefits.

Recommendations

To address these findings, the report authors issue four recommendations:

  1. National governments, industry, and philanthropic organizations should politically support and fund a comprehensive research and development agenda to establish effective guardrails for AIxBio technologies and applications.
  2. National governments should establish institutes focused on AI safety and security, whose missions include safeguarding AIxBio capabilities.
  3. International partners should collaborate via a global platform to develop and disseminate best practices for AIxBio safeguards.
  4. Global scientific and national security communities should actively leverage AI’s beneficial applications in biosecurity and pandemic preparedness.

Why It Matters

AIxBio capabilities hold immense promise—but they also introduce unprecedented risks. Without decisive action, the race for AI supremacy could devolve into a race to the bottom on safety. National governments, industry leaders, and philanthropic organizations must champion AIxBio innovation where safety and security are not afterthoughts, but core drivers of progress—essential to unlocking the full positive potential of these powerful technologies.

Stay Informed

Sign up for our newsletter to get the latest on nuclear and biological threats.

Sign Up

AIxBio Horizon Scan Winter 2025-2026

Paper

AIxBio Horizon Scan Winter 2025-2026

The AIxBio field stands at a critical juncture where rapid capability advances are outpacing governance frameworks and safety measures. The next 18 months will likely prove pivotal in determining whether voluntary safety practices by AI companies, emerging evaluation frameworks, and international coordination efforts can keep pace with technological development.


A Framework for Managed Access to Biological AI Tools

Paper

A Framework for Managed Access to Biological AI Tools

Managed access will be critical for reducing biosecurity risks related to the misuse of biological AI tools. By working to develop best practices for each element of this framework—risk levels, tiered access, and practices to verify legitimacy—developers of biological AI tools and the broader life sciences community can reduce risks while maintaining the benefits of these tools.


AIxBio Horizon Scan: Spring 2026

Paper

AIxBio Horizon Scan: Spring 2026

Since the AIxBio Horizon Scan Winter 2025-2026 published in March 2026, there has been steady, incremental progress across AI-enabled biological tools. Protein design tools have continued to improve, agentic coding tools have matured in ways that lower barriers to computational biology, and commercial AI companies are making significant investments in the life sciences.


Close

My Resources

Subscribe to NTI

Sign up for regular updates on innovative, real-world solutions to existential threats.

Get Updates